| What is new in the management of poor ovarian response in IVF? |
15 |
| Fertility preservation options for transgender and gender-nonconforming individuals |
9 |
| Hysteroscopic myomectomy: a comparison of techniques and review of current evidence in the management of abnormal uterine bleeding |
9 |
| A critical review of recent advances in the diagnosis, classification, and management of uterine adenomyosis |
8 |
| Expanding adolescent access to hormonal contraception: an update on over-the-counter, pharmacist prescribing, and web-based telehealth approaches |
8 |
| Obesity and abnormal glucose tolerance in the offspring of mothers with diabetes |
7 |
| Implantation failure of endometrial origin: what is new? |
7 |
| Advances in targeting HER2-positive breast cancer |
7 |
| Therapeutic strategies involving uterine stem cells in reproductive medicine |
6 |
| The use of technology in the sexual health education especially among minority adolescent girls in the United States |
6 |
| Pregnancy outcome in mothers over the age of 35 |
5 |
| Clinical significance of cerebroplacental ratio |
5 |
| Treatment potential of bone marrow-derived stem cells in women with diminished ovarian reserves and premature ovarian failure |
5 |
| Copy number variations and fetal ventriculomegaly |
5 |
| Adverse events related to Trendelenburg position during laparoscopic surgery: recommendations and review of the literature |
5 |
| Vasa previa: prenatal diagnosis and management |
4 |
| Endocrine therapy in ovarian cancer: where do we stand? |
4 |
| The patient perspective: perceptions of the quality of the abortion experience |
4 |
| Antibody-drug conjugates for ovarian cancer: current clinical development |
4 |
| Diminished ovarian reserve versus ovarian aging: overlaps and differences |
4 |
| Molecular characterization of endometrial cancer and therapeutic implications |
3 |
| Single-cell sequencing in ovarian cancer: a new frontier in precision medicine |
3 |
| A Strength, Weaknesses, Opportunities and Threats analysis on time lapse |
3 |
| Revisiting the basis for haemoglobin screening in pregnancy |
3 |
| Corynebacterium kroppenstedtii: a challenging culprit in breast abscesses and granulomatous mastitis |
3 |
| Neurological diseases in pregnancy |
3 |
| Recognizing maternal mental health disorders: beyond postpartum depression |
3 |
| The prevalence of occult leiomyosarcoma in women undergoing presumed fibroid surgery and outcomes after morcellation |
3 |
| Morcellation equipment: past, present, and future |
3 |
| Minimally invasive gynecologic surgery in the pregnant patient: considerations, techniques, and postoperative management per trimester |
3 |
| Into the void: a review of postoperative urinary retention after minimally invasive gynecologic surgery |
3 |
| Extracellular vesicles: a promising tool for assessment of embryonic competence |
3 |
| Embryo morphokinetic characteristics and euploidy |
3 |
| Mentoring millennials in surgical education |
3 |
| Impact of obesity on male and female reproductive outcomes |
2 |
| Should we consider telomere length and telomerase activity in male factor infertility? |
2 |
| Antenatal treatment options for primary cytomegalovirus infections |
2 |
| Endometrioma, fertility, and assisted reproductive treatments: connecting the dots |
2 |
| Frontline therapy of ovarian cancer: trials and tribulations |
2 |
| The target invites a foe: antibody-drug conjugates in gynecologic oncology |
2 |
| Hormone receptor positive breast cancer: state of the art |
2 |
| Advances in the management of endometriosis in the adolescent |
2 |
| Development and history of morcellators |
2 |
| The advent of human papillomavirus detection for cervical screening |
2 |
| Emerging technologies in pediatric gynecology: new paradigms in women's health care |
2 |
| Artificial intelligence and augmented reality in gynecology |
2 |
| Metabolism of the oocyte and the preimplantation embryo: implications for assisted reproduction |
2 |
| Pericoital contraception |
2 |
| Poly-ADP-ribosyl-polymerase inhibitor resistance mechanisms and their therapeutic implications |
2 |
| Individualized luteal phase support |
2 |
